药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
伪-Methylfentanyl
IMC-1C11
Estradiol cypionate may increase the thrombogenic activities of IMC-1C11.
伪-Methylfentanyl
Caplacizumab
Estradiol cypionate may increase the thrombogenic activities of Caplacizumab.
伪-Methylfentanyl
TB-402
Estradiol cypionate may increase the thrombogenic activities of TB-402.
伪-Methylfentanyl
IPH 2101
Estradiol cypionate may increase the thrombogenic activities of IPH 2101.
伪-Methylfentanyl
Olaratumab
Estradiol cypionate may increase the thrombogenic activities of Olaratumab.
伪-Methylfentanyl
Glembatumumab vedotin
Estradiol cypionate may increase the thrombogenic activities of Glembatumumab vedotin.
伪-Methylfentanyl
Leronlimab
Estradiol cypionate may increase the thrombogenic activities of Leronlimab.
伪-Methylfentanyl
CT-011
Estradiol cypionate may increase the thrombogenic activities of CT-011.
伪-Methylfentanyl
MYO-029
Estradiol cypionate may increase the thrombogenic activities of MYO-029.
伪-Methylfentanyl
RI 624
Estradiol cypionate may increase the thrombogenic activities of RI 624.
伪-Methylfentanyl
TNX-901
Estradiol cypionate may increase the thrombogenic activities of TNX-901.
伪-Methylfentanyl
PRO-542
Estradiol cypionate may increase the thrombogenic activities of PRO-542.
伪-Methylfentanyl
Ustekinumab
Estradiol cypionate may increase the thrombogenic activities of Ustekinumab.
伪-Methylfentanyl
Veltuzumab
Estradiol cypionate may increase the thrombogenic activities of Veltuzumab.
伪-Methylfentanyl
Farletuzumab
Estradiol cypionate may increase the thrombogenic activities of Farletuzumab.
伪-Methylfentanyl
Ramucirumab
Estradiol cypionate may increase the thrombogenic activities of Ramucirumab.
伪-Methylfentanyl
Enokizumab
Estradiol cypionate may increase the thrombogenic activities of Enokizumab.
伪-Methylfentanyl
Iratumumab
Estradiol cypionate may increase the thrombogenic activities of Iratumumab.
伪-Methylfentanyl
AMG 108
Estradiol cypionate may increase the thrombogenic activities of AMG 108.
伪-Methylfentanyl
Otelixizumab
Estradiol cypionate may increase the thrombogenic activities of Otelixizumab.